March 2023 – BIORCHESTRA

BIORCHESTRA Pens a Pact Worth up to $861M for Central Nervous System(CNS)-Targeted Polymeric Nanoparticle for Intravenous Delivery of Nucleic Acid Therapies

Post author:biorchestra
Post published:March 27, 2023
Post category:Press Release
Post comments:0 Comments

Back to list BIORCHESTRA Pens a Pact Worth up to $861M for Central Nervous System(CNS)-Targeted Polymeric Nanoparticle for Intravenous Delivery of Nucleic Acid Therapies CAMBRIDGE, Mass. and DAEJEON, South Korea, March 27, 2023 -- BIORCHESTRA,…

주주총회 소집통지 (Notice of shareholder meeting)

Post author:biorchestra
Post published:March 16, 2023
Post category:Notice
Post comments:0 Comments

Back to list 주주총회 소집통지 (Notice of shareholder meeting) 주주님, 여러분의 행복과 평안하심을 기원합니다. 상법 제365조 및 당사 정관 제25조 규정에 의거, 정기주주총회를 아래와 같이 개최하고자 하오니, 참석하여 주시기 바랍니다. ◈…

BIORCHESTRA Participating in Two Upcoming Therapeutic RNA-Focused Events

Post author:biorchestra
Post published:March 14, 2023
Post category:Press Release
Post comments:0 Comments

Back to list BIORCHESTRA Participating in Two Upcoming Therapeutic RNA-Focused Events CAMBRIDGE, Mass. and DAEJEON, South Korea, March 8, 2023 /PRNewswire/ -- BIORCHESTRA, a biotherapeutics company focused on the treatment of rare and degenerative diseases within…